Tongue Cancer Recruiting Phase 1 Trials for DB01229 (Paclitaxel)

IndicationStatusPhase
DBCOND0029843 (Tongue Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01847326Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerTreatment